Factor XI is a substrate for oxidoreductases: Enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis

详细信息    查看全文

• 作者：Bill Giannakopoulos ; Lu Gao ; Miao Qi ; Jason W. Wong ; Demin M. Yu ; Panayiotis G. Vlachoyiannopoulos ; Harry M. Moutsopoulos ; Tatsuya Atsumi ; Takao Koike ; Philip Hogg ; Jian C. Qi ; Steven A. Krilis
• 关键词：Factor XI ; Oxidoreductases ; Allosteric disulfide bonds ; Thioredoxin ; Antiphospholipid syndrome
• 刊名：Journal of Autoimmunity
• 出版年：2012
• 出版时间：September, 2012
• 年：2012
• 卷：39
• 期：3
• 页码：121-129
• 全文大小：822 K

文摘

Factor XI (FXI), a disulfide-linked covalent homodimer, circulates in plasma, and upon activation initiates the intrinsic/consolidation phase of coagulation. We present evidence that disulfide bonds in FXI are reduced to free thiols by oxidoreductases thioredoxin-1 (TRX-1) and protein disulfide isomerase (PDI). We identified that Cys362-Cys482 and Cys118-Cys147 disulfide bonds are reduced by TRX-1. The activation of TRX-1-treated FXI by thrombin, FXIIa or FXIa was significantly increased compared to non-reduced FXI, indicating that the reduced factor is more efficiently activated than the oxidized protein. Using a novel ELISA system, we compared the amount of reduced FXI in antiphospholipid syndrome (APS) thrombosis patients with levels in healthy controls, and found that APS patients have higher levels of reduced FXI. This may have implication for understanding the contribution of FXI to APS thrombosis, and the predisposition to thrombosis in patients with elevated plasma levels of reduced FXI.